PURLs

It’s Time to Use an Age-based Approach to D-dimer

Author and Disclosure Information

 

STUDY SUMMARY

Using age-adjusted d-dimer cutoffs significantly reduced false-positives

Schouten et al1 performed a systematic review and meta-analysis of studies of older patients with suspected VTE who had d-dimer testing using both conventional and age-adjusted cutoff values. The authors searched Medline and Embase for studies that were performed in outpatient, inpatient, or emergency department settings. They excluded studies of high-risk patients, specifically perioperative patients and those who’d had VTE, cancer, or a coagulation disorder.

Five high-quality studies of 13 cohorts were included in this analysis (N = 12,497; 6,969 patients older than 50). Each of these studies was a retrospective analysis of patients with a low clinical probability of VTE, as determined by Geneva or Wells scoring. The authors calculated the VTE prevalence and d-dimer sensitivity and specificity for patients ages ≤ 50, 51 to 60, 61 to 70, 71 to 80, and > 80.

The specificity of the conventional d-dimer cutoff value for VTE decreased with age from 57.6% in those ages 51 to 60 to 14.7% in those older than 80. When age-adjusted cutoffs were used (age in years × 10 μg/L), specificities improved in all age categories, particularly for older patients. For example, using age-adjusted cutoff values improved specificity to 62.3% in patients ages 51 to 60 and to 35.2% in those older than 80 (see table). Using a hypothetical model, Schouten et al1 calculated that applying age-adjusted cutoff values would exclude VTE in 303/1,000 patients older than 80, compared with 124/1,000 when using the conventional cutoff.

The benefit of using an age-adjusted cutoff is the ability to exclude VTE in more patients (1 out of 3 in those older than 80) while not significantly increasing the number of missed VTE. In fact, the number of missed cases in the older population using the age-adjusted cutoff (approximately 1 to 4 per 1,000 patients) is comparable to the false-negative rate in those ages 50 and younger (3 per 1,000). The advantages are most notable with the use of enzyme linked fluorescent assays because these assays have a higher sensitivity and a trend toward lower specificity compared with other assays.

Continued on next page >>

Recommended Reading

Rethinking antibiotics for sinusitis—again
Clinician Reviews
Grand Rounds: Woman, 38, With Pulseless Electrical Activity
Clinician Reviews
Cough and Back Pain in a Man With COPD
Clinician Reviews
Asthma medications
Clinician Reviews
Dexamethasone improves outcomes for infants with bronchiolitis, atopy history
Clinician Reviews
Estrogen-related VTE shows low recurrence rate
Clinician Reviews
Woman, 78, With Dyspnea, Dry Cough, and Fatigue
Clinician Reviews
Steroids for Acute COPD—But for How Long?
Clinician Reviews
Asthma May Increase Risk of Cardiovascular Events
Clinician Reviews
Unusual Case of Chest and Left Arm Pain
Clinician Reviews